Your browser doesn't support javascript.
loading
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation.
Gilan, Omer; Rioja, Inmaculada; Knezevic, Kathy; Bell, Matthew J; Yeung, Miriam M; Harker, Nicola R; Lam, Enid Y N; Chung, Chun-Wa; Bamborough, Paul; Petretich, Massimo; Urh, Marjeta; Atkinson, Stephen J; Bassil, Anna K; Roberts, Emma J; Vassiliadis, Dane; Burr, Marian L; Preston, Alex G S; Wellaway, Christopher; Werner, Thilo; Gray, James R; Michon, Anne-Marie; Gobbetti, Thomas; Kumar, Vinod; Soden, Peter E; Haynes, Andrea; Vappiani, Johanna; Tough, David F; Taylor, Simon; Dawson, Sarah-Jane; Bantscheff, Marcus; Lindon, Matthew; Drewes, Gerard; Demont, Emmanuel H; Daniels, Danette L; Grandi, Paola; Prinjha, Rab K; Dawson, Mark A.
Afiliación
  • Gilan O; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Rioja I; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Knezevic K; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
  • Bell MJ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Yeung MM; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
  • Harker NR; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Lam EYN; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
  • Chung CW; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Bamborough P; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Petretich M; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
  • Urh M; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
  • Atkinson SJ; Cellzome GmbH, Functional Genomics R&D, GlaxoSmithKline, Heidelberg, Germany.
  • Bassil AK; Promega Corporation, Madison, WI, USA.
  • Roberts EJ; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
  • Vassiliadis D; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
  • Burr ML; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
  • Preston AGS; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Wellaway C; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Werner T; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Gray JR; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Michon AM; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
  • Gobbetti T; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
  • Kumar V; Cellzome GmbH, Functional Genomics R&D, GlaxoSmithKline, Heidelberg, Germany.
  • Soden PE; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
  • Haynes A; Cellzome GmbH, Functional Genomics R&D, GlaxoSmithKline, Heidelberg, Germany.
  • Vappiani J; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
  • Tough DF; Computational Biology, GlaxoSmithKline, Collegeville, PA, USA.
  • Taylor S; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
  • Dawson SJ; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
  • Bantscheff M; Cellzome GmbH, Functional Genomics R&D, GlaxoSmithKline, Heidelberg, Germany.
  • Lindon M; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
  • Drewes G; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
  • Demont EH; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Daniels DL; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Grandi P; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia.
  • Prinjha RK; Cellzome GmbH, Functional Genomics R&D, GlaxoSmithKline, Heidelberg, Germany.
  • Dawson MA; Epigenetics RU, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
Science ; 368(6489): 387-394, 2020 04 24.
Article en En | MEDLINE | ID: mdl-32193360
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Antiinflamatorios no Esteroideos / Proteínas de Ciclo Celular / Histona Acetiltransferasas / Terapia Molecular Dirigida / Factores Inmunológicos / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Science Año: 2020 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Antiinflamatorios no Esteroideos / Proteínas de Ciclo Celular / Histona Acetiltransferasas / Terapia Molecular Dirigida / Factores Inmunológicos / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Science Año: 2020 Tipo del documento: Article País de afiliación: Australia